IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value
$85.35+0.12 (+0.14%)
Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –
IRadimed cash
Cash and short-term investments held at the end of each period.
IRadimed's cash was $63.29M at Sep 30, 2026. For fiscal 2025 it was $51.16M, down 2.1% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $62.00M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.16M | -2.1% |
| FY2024 | Dec 31, 2024 | $52.23M | +5.0% |
| FY2023 | Dec 31, 2023 | $49.76M | -14.1% |
| FY2022 | Dec 31, 2022 | $57.96M | -6.5% |
| FY2021 | Dec 31, 2021 | $62.00M | +23.8% |
| FY2020 | Dec 31, 2020 | $50.07M | +15.1% |
| FY2019 | Dec 31, 2019 | $43.48M | +55.1% |
| FY2018 | Dec 31, 2018 | $28.03M | +53.9% |
| FY2017 | Dec 31, 2017 | $18.21M | +2.8% |
| FY2016 | Dec 31, 2016 | $17.71M | -8.5% |
| FY2015 | Dec 31, 2015 | $19.37M | +104.9% |
| FY2014 | Dec 31, 2014 | $9.45M | +284.1% |
| FY2013 | Dec 31, 2013 | $2.46M | +45.0% |
| FY2012 | Dec 31, 2012 | $1.70M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $63.29M | +12.0% |
| Q2 FY2026 | Jun 30, 2026 | $59.08M | +11.5% |
| Q1 FY2026 | Mar 31, 2026 | $56.37M | +12.0% |
| Q4 FY2025 | Dec 31, 2025 | $51.16M | -2.1% |
| Q3 FY2025 | Sep 30, 2025 | $56.53M | +9.3% |
| Q2 FY2025 | Jun 30, 2025 | $53.00M | +9.2% |
| Q1 FY2025 | Mar 31, 2025 | $50.33M | +11.5% |
| Q4 FY2024 | Dec 31, 2024 | $52.23M | +5.0% |
| Q3 FY2024 | Sep 30, 2024 | $51.72M | +10.6% |
| Q2 FY2024 | Jun 30, 2024 | $48.54M | +5.9% |
| Q1 FY2024 | Mar 31, 2024 | $45.13M | +5.5% |
| Q4 FY2023 | Dec 31, 2023 | $49.76M | -14.1% |
| Q3 FY2023 | Sep 30, 2023 | $46.75M | -15.9% |
| Q2 FY2023 | Jun 30, 2023 | $45.82M | -12.1% |
| Q1 FY2023 | Mar 31, 2023 | $42.78M | -15.2% |
| Q4 FY2022 | Dec 31, 2022 | $57.96M | -6.5% |
| Q3 FY2022 | Sep 30, 2022 | $55.59M | -4.8% |
| Q2 FY2022 | Jun 30, 2022 | $52.16M | -5.4% |
| Q1 FY2022 | Mar 31, 2022 | $50.45M | -0.7% |
| Q4 FY2021 | Dec 31, 2021 | $62.00M | +23.8% |
| Q3 FY2021 | Sep 30, 2021 | $58.37M | +22.8% |
| Q2 FY2021 | Jun 30, 2021 | $55.16M | +21.3% |
| Q1 FY2021 | Mar 31, 2021 | $50.80M | +13.8% |
| Q4 FY2020 | Dec 31, 2020 | $50.07M | +15.1% |
| Q3 FY2020 | Sep 30, 2020 | $47.55M | +23.1% |
| Q2 FY2020 | Jun 30, 2020 | $45.46M | +40.2% |
| Q1 FY2020 | Mar 31, 2020 | $44.64M | +50.4% |
| Q4 FY2019 | Dec 31, 2019 | $43.48M | +55.1% |
| Q3 FY2019 | Sep 30, 2019 | $38.64M | +63.0% |
| Q2 FY2019 | Jun 30, 2019 | $32.42M | +52.0% |
| Q1 FY2019 | Mar 31, 2019 | $29.68M | +47.7% |
| Q4 FY2018 | Dec 31, 2018 | $28.03M | +53.9% |
| Q3 FY2018 | Sep 30, 2018 | $23.70M | +28.8% |
| Q2 FY2018 | Jun 30, 2018 | $21.33M | +27.0% |
| Q1 FY2018 | Mar 31, 2018 | $20.09M | +15.1% |
| Q4 FY2017 | Dec 31, 2017 | $18.21M | +2.8% |
| Q3 FY2017 | Sep 30, 2017 | $18.41M | – |
| Q2 FY2017 | Jun 30, 2017 | $16.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $17.46M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.71M | – |
See a number that looks wrong?